Document is current
Any future updates will be listed below
-
Authors
Saltarella, Ilaria
Morabito, Fortunato
Giuliani, Nicola
Terragna, Carolina
Omedè, Paola
Palumbo, Antonio
Bringhen, Sara
De Paoli, Lorenzo
Martino, Enrica
Larocca, Alessandra
Offidani, Massimo
Patriarca, Francesca
Nozzoli, Chiara
Guglielmelli, Tommasina
Benevolo, Giulia
Callea, Vincenzo
Baldini, Luca
Grasso, Mariella
Leonardi, Giovanna
Rizzo, Manuela
Falcone, Antonietta Pia
Gottardi, Daniela
Montefusco, Vittorio
Musto, Pellegrino
Petrucci, Maria Teresa
Dammacco, Franco
Boccadoro, Mario
Vacca, Angelo
Ria, Roberto http://orcid.org/0000-0002-1515-0090
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (14095, 9965)
- License Information
-
More Information
Article History
Received: 22 September 2018
Accepted: 25 December 2018
First Online: 9 January 2019
Ethics approval and consent to participate
: The Local IRB approved this study and all patients gave their informed consent before the entry into the clinical trial in agreement with institutional guidelines.
: Not applicable.
: Lorenzo De Paoli: honorary from Jansen, Abbvie, Celgene, Gilead, AMGEN, and Roche. Massimo Offidani: honorary and advisory from Janssen. Maria Teresa Petrucci: Honoraria and Advisory Board: Celgene, Janssen-Cilag, BMS, Takeda, Amgen. Roberto Ria: Honoraria and Advisory Board: Celgene, Janssen-Cilag, BMS, Italfarmaco, Amgen. The other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
